Intratympanic Dexamethasone/Hyaluronic Acid Mix as an Adjunct to Intravenous Steroid and Vasoactive Treatment in Patients With Severe Idiopathic Sudden Sensorineural Hearing Loss
Authors:
- Haralampos GouverisHGHaralampos Gouveris
- Wiebke Schuler-SchmidtWSWiebke Schuler-Schmidt
- Torsten MewesTMTorsten Mewes
- Wolf MannWMWolf Mann
- 1 July 2011
- journal article
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 32 (5) , 756-760
Abstract
To evaluate differences in effectiveness (hearing recovery rates) between idiopathic sudden sensorineural hearing loss (ISSNHL) patients treated with intravenous therapy alone and patients treated with a combination of intravenous and intratympanic therapy. Retrospective case review. Tertiary referral hospital center. Ninety-four patients with moderate ISSNHL treated with an intravenous steroid and vasoactive regimen (duration of therapy, 9 ± 2.76 d) and 76 patients with severe ISSNHL treated with a combination regimen of intravenous and intratympanic therapy (duration of therapy, 10 ± 2.71 d) were reviewed. In the latter patients' group, a series of 3 intratympanic injections of a dexamethasone/hyaluronic acid mix solution were applied every 2 days. Pure-tone audiometric thresholds at 0.5, 1, 2, 4, and 8 kHz were compared between groups using the Wilcoxon test. Combination therapy in severe ISSNHL did not show any statistically significant difference in effectiveness to intravenous therapy in moderate ISSNHL (p > 0.05). In patients with severe ISSNHL, starting intratympanic steroid therapy as an adjunct early in the course of intravenous steroid and vasoactive therapy improves hearing to a level which is obtained in patients with less severe (moderate) ISSNHL treated with intravenous therapy alone.Keywords
This publication has 17 references indexed in Scilit:
- Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHLOtolaryngology–Head and Neck Surgery, 2009
- Diabetes, Cardiovascular Risk Factors and Idiopathic Sudden Sensorineural Hearing Loss: A Case-Control StudyAudiology and Neurotology, 2009
- Dexamethasone Concentration Gradients Along Scala Tympani After Application to the Round Window MembraneOtology & Neurotology, 2008
- Sudden Deafness: Is It Viral?ORL, 2008
- Intratympanic Injection of DexamethasoneOtology & Neurotology, 2006
- Intratympanic Corticosteroids for Sudden Idiopathic Sensorineural Hearing LossOtology & Neurotology, 2005
- Intratympanic Dexamethasone and Hyaluronic Acid in Patients with Low-Frequency and Ménière's-Associated Sudden Sensorineural Hearing LossOtology & Neurotology, 2005
- Effectiveness of Intratympanic Dexamethasone Injection in Sudden‐Deafness Patients as Salvage TreatmentThe Laryngoscope, 2004
- Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapyEuropean Archives of Oto-Rhino-Laryngology, 2004
- Intratympanic Dexamethasone for Sudden Sensorineural Hearing Loss: Clinical and Laboratory EvaluationOtology & Neurotology, 2001